[CAZENOVIA, NY – March 23, 2023] – Three leading medically integrated oncology practices were awarded NCODA’s Center of Excellence Medically Integrated Pharmacy Accreditation at the NCODA International Spring Forum that took place on March 15 – 17, 2023 in Indianapolis, IN. The newly accredited practices include Clearview Cancer Institute, Rx To Go, LLC at Florida Cancer Specialists & Research Institute, and Southern Oncology and Hematology Associates.

“Participating in the NCODA MIP Accreditation has been a valuable opportunity for our team and patients,” said Kara Sammons, Director of Quality and Compliance – Pharmacy for Rx To Go. “The emphasis on medical integration, and its importance in the oncology care model, has been very constructive for everyone involved. At Rx To Go, we do a tremendous job supporting our patients and our team. Prior to this process, we had already adopted patient-centered practices; however, we are constantly striving for enhancements and this accreditation allows us just that. We look forward to having more involvement in the NCODA community.”

This three-year accreditation, based on compliance with the ASCO/NCODA Patient-Centered Standards for Medically Integrated Dispensing is the only accreditation program designed specifically for medically integrated practices. The CoE MIP Accreditation eliminates clinical fragmentation and administrative burdens and provides innovative standards and tools specifically designed to improve outcomes and enhance the quality of services.

“Even though we have URAC and ACHC accreditation, we decided to pursue NCODA’s accreditation because we felt it would benefit our practice,” said Meg Butler, PharmD, with Clearview Cancer Center. “Not only is NCODA’s accreditation patient-centered and focused, but it also challenges us to be a better medically integrated dispensing pharmacy as it tracks multiple aspects of the patient journey throughout oncology.”

“Getting accreditation with NCODA has assured our patients that the level and quality of care we provide is amongst the best in the nation,” said Samuel Hernandez, Pharmacy Technician, Dispensary Lead at Southern Oncology and Hematology Associates.

Earlier this year, NCODA announced the expansion of the accreditation program to include Multi-Specialty and Multi-Specialty with Oncology Focus. These new offerings allow medically integrated pharmacies servicing multiple disease states to benefit from a patient-centered accreditation program without the presence of administrative burdens.


NCODA is a leading non-profit organization dedicated to empowering medically-integrated oncology practices to deliver positive, patient-centered outcomes by providing leadership, expertise, quality standards, and best practices. To learn more about NCODA visit www.ncoda.org or follow @NCODA on LinkedIn.

For More Information, Contact:
Katie Edmiston, Senior Manager of Marketing & Communications
(813) 843-1629


Clearview Cancer Institute
Clearview Cancer Institute (CCI) offers comprehensive cancer care in an outpatient setting.  With more than 60 healthcare providers and 13 locations across north Alabama, CCI is a leader in medical oncology and has been providing oncology and hematology services for more than 30 years. For more information visit clearviewcancer.com.


About Florida Cancer Specialists & Research Institute, LLC: (FLCancer.com)
Recognized by the American Society of Clinical Oncology (ASCO) with a national Clinical Trials Participation Award, Florida Cancer Specialists & Research Institute (FCS) offers patients access to more clinical trials than any private oncology practice in Florida. The majority of new cancer drugs recently approved for use in the U.S. were studied in clinical trials with Florida Cancer Specialists participation.* Trained in prestigious medical schools and research institutes, our physicians are consistently ranked nationally as Top Doctors by U.S. News & World Report.

Founded in 1984, Florida Cancer Specialists has built a national reputation for excellence that is reflected in exceptional and compassionate patient care, driven by innovative clinical research, cutting-edge technologies and advanced treatments, including targeted therapies, genomic-based treatment, and immunotherapy.  Our highest values are embodied by our outstanding team of highly trained and dedicated physicians, clinicians and staff.
*Prior to approval


Southern Oncology and Hematology Associates
Southern Oncology and Hematology Associates is a leader in providing patients the highest quality of care, compassion, confidence, and commitment for over 45 years. For more information visit southeroncology.net.